Tomorrow Investor

SAGA Metals Reports Assays from R-0039 to R-0043 with Intercepts Including 51.20% FeO, 7.94% TiO, 0.340% VO from 2026 Drilling at Trapper South, Radar Critical Minerals Project in Labrador

SAGA Metals Reports Critical Mineral Assays at Trapper South | Newsfile Corp

Vancouver, British Columbia–(Newsfile Corp. – June 4, 2026) – SAGA Metals Corp. (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H) (“SAGA” or the “Company”), a North American exploration company focused on critical mineral discoveries, is pleased to report additional assay results from drill holes R-0039, -0040, -0041, -0042 and -0043 completed in 2026 as part of its ongoing maiden Mineral Resource Estimate (“MRE”) diamond drill program at the Trapper Zone within the 100%-owned Radar Titanium-Vanadium-Iron Project near Cartwright, Labrador, Canada. The Trapper Zone forms part of an oxide corridor that includes the Falcon and Hawkeye Zones spanning 29 square kilometres near the center of the Property.

This excerpt is quoted from the original release. Read the full announcement on Newsfile Corp.

Brief Summary

SAGA Metals Corp. (TSXV: SAGA) has announced additional assay results from their ongoing exploration at the Radar Project.

  • 51.20% FeO and 7.94% TiO intercepts reported
  • Drill holes R-0039 to R-0043 yield positive results
  • Focus on critical minerals for sustainable energy
  • Located in Cartwright, Labrador
  • Part of a larger Mineral Resource Estimate program

Why it matters: These results enhance SAGA’s position in the critical minerals sector, promising growth potential.

Read the Full Article

This is a summary of the press release. For the complete article and any additional details, please visit the original source.

Read Full Article

Attribution: Original press release by Newsfile Corp on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.

Tomorrow Investor
The Tomorrow Investor

Markets research for retail investors

Independent coverage of small-cap equities, biotech catalysts, and emerging market opportunities.